reference/6013496

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6013496

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1323
issn	1538-8514 1535-7163
issueIdentifier	7
pageRange	1312-1323
publicationName	Molecular Cancer Therapeutics
startingPage	1312
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b7b8c7bd395e7f9fb10f96ad286b39d3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ec9fe40f453b107a543973ff375c30ee
bibliographicCitation	Le Clorennec C, Bazin H, Dubreuil O, Larbouret C, Ogier C, Lazrek Y, Garambois V, Poul MA, Mondon P, Barret JM, Mathis G, Prost JF, Pèlegrin A, Chardès T. Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3. Mol Cancer Ther. 2017 Jul;16(7):1312–23. doi: 10.1158/1535-7163.mct-16-0886. PMID: 28507002.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c21fd7817bcd9b6215a71adaf83de59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8188f06e2457bed41f69df9d3bf92f3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63e52b0790b97732f1827c7b5beba65d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebf29830e4417e973d575f7991b36801 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b38d316d90d5e655bab87537390e32e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91d767382f88ae10286d8c05dd7cc201 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2ee86763579294e7169c665f52480b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9254-2648 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbdf662c0987e429c49c759cd6914ed2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3538-2200 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1836-7439 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b400526bd92333532438d6996fab82b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76d0bb4151f821d30a76a18546a2ff38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74fe99cbd15068c8f4d43dba5b750f03 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7157-064X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48cfa00bfef4d4ad1b6c48dc17601555 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84967a631cc1674ca6fba2d1bc699e60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0115e12a927b85d590612db32d605582
date	2017-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1535-7163.mct-16-0886 https://pubmed.ncbi.nlm.nih.gov/28507002
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097 https://portal.issn.org/resource/ISSN/1535-7163 https://portal.issn.org/resource/ISSN/1538-8514
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3
discusses	http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0248043 http://id.nlm.nih.gov/mesh/M0585103 http://id.nlm.nih.gov/mesh/M000640407 http://id.nlm.nih.gov/mesh/M0328212 http://id.nlm.nih.gov/mesh/M0328262 http://id.nlm.nih.gov/mesh/M0001324 http://id.nlm.nih.gov/mesh/M0544940
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014408Q000276 http://id.nlm.nih.gov/mesh/D058846Q000008 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D020893Q000276 http://id.nlm.nih.gov/mesh/D020890Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D011485 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000072283 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D000888Q000276 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D031541 http://id.nlm.nih.gov/mesh/D000888Q000008 http://id.nlm.nih.gov/mesh/D058846Q000276 http://id.nlm.nih.gov/mesh/D009369Q000473 http://id.nlm.nih.gov/mesh/D020893Q000037 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D020890Q000276 http://id.nlm.nih.gov/mesh/D009369Q000276 http://id.nlm.nih.gov/mesh/D009369Q000235 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_209caecd4cc3a932d43a03af0869bfa7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_79ad58d09e4d39d7b6c4574fc8a98844 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_95d926625e5919a35cb6aa367ba7b069 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fadc3c8509db129e10ef4cfccf6efc5d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d7d07219eb0333b77b9c1ec30e7594d4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID2989

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3084 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2065

Total number of triples: 85.